Cross Country Healthcare, Inc. (CCRN)
USD 14.38
(0.35%)
USD 14.38
(0.35%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 2.66 Million USD | -98.27% |
| 2022 | 153.61 Million USD | -17.95% |
| 2021 | 187.21 Million USD | 172.75% |
| 2020 | 68.64 Million USD | -23.77% |
| 2019 | 90.04 Million USD | 15.52% |
| 2018 | 77.94 Million USD | -15.52% |
| 2017 | 92.25 Million USD | 8.85% |
| 2016 | 84.76 Million USD | 3.61% |
| 2015 | 81.8 Million USD | 16.09% |
| 2014 | 70.46 Million USD | 75670.97% |
| 2013 | 93 Thousand USD | -47.16% |
| 2012 | 176 Thousand USD | -99.3% |
| 2011 | 25.04 Million USD | -45.02% |
| 2010 | 45.55 Million USD | -19.77% |
| 2009 | 56.78 Million USD | -51.57% |
| 2008 | 117.25 Million USD | 241.01% |
| 2007 | 34.38 Million USD | 72.11% |
| 2006 | 19.97 Million USD | 0.16% |
| 2005 | 19.94 Million USD | -49.97% |
| 2004 | 39.86 Million USD | -55.1% |
| 2003 | 88.79 Million USD | 212.08% |
| 2002 | 28.45 Million USD | -36.88% |
| 2001 | 45.07 Million USD | -68.78% |
| 2000 | 144.38 Million USD | 0.0% |
| 1999 | - USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 2.13 Million USD | 0.0% |
| 2024 Q2 | 2.65 Million USD | 0.0% |
| 2023 FY | 2.66 Million USD | -98.27% |
| 2023 Q3 | 3.04 Million USD | -91.1% |
| 2023 Q1 | 142.28 Million USD | -7.37% |
| 2023 Q4 | 2.66 Million USD | -12.4% |
| 2023 Q2 | 34.15 Million USD | -76.0% |
| 2022 Q1 | 228.17 Million USD | 21.88% |
| 2022 Q2 | 212.39 Million USD | -6.92% |
| 2022 FY | 153.61 Million USD | -17.95% |
| 2022 Q4 | 153.61 Million USD | 13.58% |
| 2022 Q3 | 135.24 Million USD | -36.32% |
| 2021 Q4 | 187.21 Million USD | 68.75% |
| 2021 Q3 | 110.94 Million USD | -10.7% |
| 2021 Q2 | 124.24 Million USD | 12.95% |
| 2021 FY | 187.21 Million USD | 172.75% |
| 2021 Q1 | 110 Million USD | 60.26% |
| 2020 Q3 | 71.8 Million USD | 9.02% |
| 2020 Q4 | 68.64 Million USD | -4.4% |
| 2020 FY | 68.64 Million USD | -23.77% |
| 2020 Q1 | 85.64 Million USD | -4.89% |
| 2020 Q2 | 65.85 Million USD | -23.1% |
| 2019 Q1 | 97.91 Million USD | 25.62% |
| 2019 Q2 | 92.06 Million USD | -5.98% |
| 2019 Q4 | 90.04 Million USD | -0.69% |
| 2019 Q3 | 90.66 Million USD | -1.51% |
| 2019 FY | 90.04 Million USD | 15.52% |
| 2018 FY | 77.94 Million USD | -15.52% |
| 2018 Q4 | 77.94 Million USD | -6.24% |
| 2018 Q3 | 83.13 Million USD | -8.14% |
| 2018 Q2 | 90.49 Million USD | -1.97% |
| 2018 Q1 | 92.31 Million USD | 0.06% |
| 2017 FY | 92.25 Million USD | 8.85% |
| 2017 Q4 | 92.25 Million USD | -3.22% |
| 2017 Q3 | 95.33 Million USD | 169.72% |
| 2017 Q2 | 35.34 Million USD | -2.28% |
| 2017 Q1 | 36.16 Million USD | -57.33% |
| 2016 Q3 | 70.23 Million USD | -9.65% |
| 2016 Q2 | 77.73 Million USD | 19.11% |
| 2016 FY | 84.76 Million USD | 3.61% |
| 2016 Q4 | 84.76 Million USD | 20.68% |
| 2016 Q1 | 65.26 Million USD | -20.21% |
| 2015 Q4 | 81.8 Million USD | 13.74% |
| 2015 Q2 | 68.65 Million USD | -0.01% |
| 2015 FY | 81.8 Million USD | 16.09% |
| 2015 Q3 | 71.91 Million USD | 4.75% |
| 2015 Q1 | 68.66 Million USD | -2.56% |
| 2014 Q2 | 53.08 Million USD | 36765.28% |
| 2014 Q1 | 144 Thousand USD | 54.84% |
| 2014 Q3 | 60.75 Million USD | 14.44% |
| 2014 Q4 | 70.46 Million USD | 15.99% |
| 2014 FY | 70.46 Million USD | 75670.97% |
| 2013 Q3 | 109 Thousand USD | -12.8% |
| 2013 Q2 | 125 Thousand USD | -12.59% |
| 2013 Q1 | 143 Thousand USD | -18.75% |
| 2013 FY | 93 Thousand USD | -47.16% |
| 2013 Q4 | 93 Thousand USD | -14.68% |
| 2012 Q1 | 16.77 Million USD | -33.02% |
| 2012 FY | 176 Thousand USD | -99.3% |
| 2012 Q2 | 32.26 Million USD | 92.34% |
| 2012 Q4 | 176 Thousand USD | -23.81% |
| 2012 Q3 | 231 Thousand USD | -99.28% |
| 2011 Q4 | 25.04 Million USD | -26.46% |
| 2011 Q1 | 42.4 Million USD | -6.92% |
| 2011 Q3 | 34.06 Million USD | -12.64% |
| 2011 Q2 | 38.98 Million USD | -8.05% |
| 2011 FY | 25.04 Million USD | -45.02% |
| 2010 Q1 | 51.56 Million USD | -9.18% |
| 2010 FY | 45.55 Million USD | -19.77% |
| 2010 Q3 | 48.71 Million USD | -3.17% |
| 2010 Q4 | 45.55 Million USD | -6.48% |
| 2010 Q2 | 50.3 Million USD | -2.45% |
| 2009 Q3 | 63.61 Million USD | -25.94% |
| 2009 FY | 56.78 Million USD | -51.57% |
| 2009 Q4 | 56.78 Million USD | -10.75% |
| 2009 Q2 | 85.9 Million USD | -21.38% |
| 2009 Q1 | 109.26 Million USD | -6.81% |
| 2008 Q4 | 117.25 Million USD | -13.27% |
| 2008 Q2 | 31.24 Million USD | -8.88% |
| 2008 Q1 | 34.29 Million USD | -0.27% |
| 2008 FY | 117.25 Million USD | 241.01% |
| 2008 Q3 | 135.19 Million USD | 332.65% |
| 2007 FY | 34.38 Million USD | 72.11% |
| 2007 Q2 | 27.5 Million USD | 12.76% |
| 2007 Q4 | 34.38 Million USD | -19.88% |
| 2007 Q3 | 42.91 Million USD | 56.03% |
| 2007 Q1 | 24.39 Million USD | 22.1% |
| 2006 FY | 19.97 Million USD | 0.16% |
| 2006 Q4 | 19.97 Million USD | 10.61% |
| 2006 Q3 | 18.06 Million USD | 121.78% |
| 2006 Q2 | 8.14 Million USD | -46.22% |
| 2006 Q1 | 15.14 Million USD | -24.08% |
| 2005 Q4 | 19.94 Million USD | -30.83% |
| 2005 Q3 | 28.83 Million USD | -19.38% |
| 2005 Q1 | 39.91 Million USD | 0.11% |
| 2005 Q2 | 35.77 Million USD | -10.38% |
| 2005 FY | 19.94 Million USD | -49.97% |
| 2004 FY | 39.86 Million USD | -55.1% |
| 2004 Q3 | 54.21 Million USD | -17.71% |
| 2004 Q2 | 65.88 Million USD | -20.46% |
| 2004 Q1 | 82.82 Million USD | -6.72% |
| 2004 Q4 | 39.86 Million USD | -26.46% |
| 2003 Q1 | 17.96 Million USD | -36.87% |
| 2003 Q3 | 112.9 Million USD | -5.06% |
| 2003 FY | 88.79 Million USD | 212.08% |
| 2003 Q2 | 118.91 Million USD | 562.01% |
| 2003 Q4 | 88.79 Million USD | -21.35% |
| 2002 FY | 28.45 Million USD | -36.88% |
| 2002 Q4 | 28.45 Million USD | -11.22% |
| 2002 Q3 | 32.04 Million USD | -10.03% |
| 2002 Q1 | 39.19 Million USD | -13.05% |
| 2002 Q2 | 35.62 Million USD | -9.11% |
| 2001 Q4 | 45.07 Million USD | -72.13% |
| 2001 FY | 45.07 Million USD | -68.78% |
| 2001 Q3 | 161.71 Million USD | 0.0% |
| 2000 FY | 144.38 Million USD | 0.0% |
| 1999 FY | - USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 1.34 Billion USD | 99.802% |
| Addus HomeCare Corporation | 124.13 Million USD | 97.855% |
| AirSculpt Technologies, Inc. | 69.5 Million USD | 96.169% |
| Amedisys, Inc. | 346.76 Million USD | 99.232% |
| American Oncology Network, Inc. | 120.44 Million USD | 97.789% |
| Astrana Health, Inc. | 296.26 Million USD | 99.101% |
| Aveanna Healthcare Holdings Inc. | 1.27 Billion USD | 99.791% |
| IMAC Holdings, Inc. | - USD | -Infinity% |
| biote Corp. | 106.63 Million USD | 97.503% |
| Cryo-Cell International, Inc. | 9.28 Million USD | 71.31% |
| COMPASS Pathways plc | 28.75 Million USD | 90.74% |
| DocGo Inc. | 15.16 Million USD | 82.436% |
| The Ensign Group, Inc. | 1.78 Billion USD | 99.851% |
| Healthcare Services Group, Inc. | 11.23 Million USD | 76.297% |
| InnovAge Holding Corp. | 100.49 Million USD | 97.35% |
| Assure Holdings Corp. | 505 Thousand USD | -427.327% |
| The Joint Corp. | 2 Million USD | -33.15% |
| LifeStance Health Group, Inc. | 280.28 Million USD | 99.05% |
| Mobile-health Network Solutions Class A Ordinary Shares | 381.43 Thousand USD | -598.146% |
| ModivCare Inc. | 983.75 Million USD | 99.729% |
| NewGenIvf Group Limited | 118.97 Thousand USD | -2138.21% |
| Novo Integrated Sciences, Inc. | 1.75 Million USD | -51.426% |
| Option Care Health, Inc. | 1.05 Billion USD | 99.748% |
| P3 Health Partners Inc. | 108.31 Million USD | 97.542% |
| P3 Health Partners Inc. | 108.31 Million USD | 97.542% |
| The Pennant Group, Inc. | 312.51 Million USD | 99.148% |
| Surgery Partners, Inc. | 2.03 Billion USD | 99.869% |
| Syra Health Corp. Class A Common Stock | - USD | -Infinity% |
| Talkspace, Inc. | - USD | -Infinity% |
| Talkspace, Inc. | - USD | -Infinity% |
| The Oncology Institute, Inc. | 86.82 Million USD | 96.933% |
| The Oncology Institute, Inc. | 86.82 Million USD | 96.933% |